CEACAM5 and cancer: CEA- and 5T4-specific TH1 and TH17 cell responses were readily identifiable amongst healthy donors and cancer patients (Supplementary Fig. 1C); these responses were predominantly MHC class II-restricted (Supplementary Fig. 1D).